Choong-kun Lee

Assistant Professor

Yonsei University College of Medicine

South Korea

Research Interests

Explore related searches

Professors in South Korea Professors in Immunology Immunology professors in South Korea

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Choong-kun Lee is an Assistant Professor at Yonsei University College of Medicine in South Korea. His research areas focus on oncology, particularly the immunogenicity and safety of cancer treatments, including vaccine responses in patients undergoing active treatment. Recent works include studies on therapeutic strategies for biliary tract cancer and the clinical relevance of cell-free DNA profiling in gastric cancer. Dr. Lee's involvement in multi-institutional trials and mixed methods studies highlights his commitment to improving cancer care and treatment outcomes.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (6)

Sun Young Rha

Yonsei University College of Medicine

SOUTH KOREA

View details

Uwe Pelzer

GERMANY

View details

Hyo Song Kim

Yonsei University College of Medicine

SOUTH KOREA

View details

Seung-Hyun Jung

SOUTH KOREA

View details

Dong-Hoe Koo

Professor

Samsung Medical Center, Sungkyunkwan University School of Medicine

SOUTH KOREA

View details

Seung-Tae Lee

Yonsei University College of Medicine

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Choong-kun Lee

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Immunogenicity and Safety of Vaccines against Coronavirus Disease in Actively Treated Patients with Solid Tumors: A Prospective Cohort Study

Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19–14)

Care Needs of Adolescents and Young Adults with Cancer Undergoing Active Treatment in South Korea: A Mixed Methods Study

Clinical relevance of clonal hematopoiesis and its interference in cell-free DNA profiling of patients with gastric cancer

Monitoring the Outcomes of Systemic Chemotherapy Including Immune Checkpoint Inhibitor for HER2-Positive Metastatic Gastric Cancer by Liquid Biopsy

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers

Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer – Authors' reply

A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancer

Analytical and Clinical Validation of Cell-Free Circulating Tumor DNA Assay for the Estimation of Tumor Mutational Burden

Collaborators (6)

Sun Young Rha

Uwe Pelzer

Hyo Song Kim

Seung-Hyun Jung

Dong-Hoe Koo

Seung-Tae Lee

Make your next move.